FCHS Revenue Halves, Net Loss Persists Amidst Mounting Debt
Ticker: FCHS · Form: 10-Q · Filed: Aug 13, 2025 · CIK: 1416876
Sentiment: bearish
Topics: Healthcare Services, Financial Distress, Liquidity Crisis, Declining Revenue, High Debt, Going Concern, Small Cap
TL;DR
**FCHS is a burning dumpster fire, avoid at all costs; the PPP loan forgiveness is a band-aid on a gaping wound.**
AI Summary
First Choice Healthcare Solutions, Inc. (FCHS) reported a significant net loss of $2,037,329 for the six months ended June 30, 2025, a 34.4% improvement from the $3,114,119 net loss in the prior year period. Revenue, net of discounts, decreased substantially by 46.3% to $5,456 for the six months ended June 30, 2025, compared to $10,154 in the same period of 2024. The company's operating loss widened to $1,158,872 from $975,821 year-over-year. A key positive financial event was the forgiveness of a PPP Loan totaling $471,300 during the six months ended June 30, 2025. Despite this, total liabilities increased to $38,778,384 as of June 30, 2025, from $36,982,542 at December 31, 2024, driven by a rise in accounts payable and accrued expenses to $10,339,589 and notes payable to $24,976,240. Cash and cash equivalents plummeted to $6,454 as of June 30, 2025, from $19,915 at December 31, 2024, indicating severe liquidity challenges. The company continues to operate with a substantial accumulated deficit, reaching $69,818,477 by June 30, 2025.
Why It Matters
This filing paints a grim picture for FCHS, indicating severe operational and financial distress. For investors, the plummeting revenue and increasing liabilities, coupled with minimal cash, suggest a high risk of further dilution or even bankruptcy. Employees face uncertainty given the company's inability to generate meaningful revenue. Customers might experience service disruptions if the company's financial health deteriorates further. In a competitive healthcare market, FCHS's struggles highlight the challenges smaller, growth-focused companies face without strong financial backing and a clear path to profitability, potentially signaling consolidation opportunities for larger, more stable players.
Risk Assessment
Risk Level: high — The company's cash and cash equivalents are critically low at $6,454 as of June 30, 2025, down from $19,915 at December 31, 2024. Total current liabilities of $35,693,739 significantly outweigh total current assets of $15,913, indicating severe liquidity issues and a going concern risk. The accumulated deficit has grown to $69,818,477, demonstrating a long history of unprofitability.
Analyst Insight
Investors should immediately divest any holdings in FCHS. The company's financial statements show a clear pattern of declining revenue, increasing debt, and minimal cash, making it an extremely high-risk investment with little to no upside potential in the near term. Focus on companies with robust revenue growth and positive cash flow.
Financial Highlights
- revenue
- $5,456
- total Debt
- $38,778,384
- net Income
- -$2,037,329
- cash Position
- $6,454
- revenue Growth
- -46.3%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Total Revenue | $5,456 | -46.3% |
Key Numbers
- $2.04M — Net Loss (For the six months ended June 30, 2025, a 34.4% improvement from $3.11M in 2024, but still substantial.)
- $5.46K — Revenue (For the six months ended June 30, 2025, a 46.3% decrease from $10.15K in 2024, indicating severe operational decline.)
- $471.3K — PPP Loan Forgiveness (Recognized as other income for the six months ended June 30, 2025, providing a temporary boost.)
- $6.45K — Cash and Cash Equivalents (As of June 30, 2025, a critical decline from $19.92K at December 31, 2024, highlighting liquidity issues.)
- $38.78M — Total Liabilities (As of June 30, 2025, an increase from $36.98M at December 31, 2024, driven by notes payable and accounts payable.)
- $69.82M — Accumulated Deficit (As of June 30, 2025, indicating a long history of unprofitability and negative equity.)
- $24.98M — Notes Payable (As of June 30, 2025, a significant portion of current liabilities, up from $24.27M at December 31, 2024.)
- $1.16M — Operating Loss (For the six months ended June 30, 2025, widening from $975.82K in 2024, showing core business struggles.)
- 32,958,288 — Common Shares Outstanding (Consistent at June 30, 2025, and December 31, 2024, but potential dilution from anti-dilutive securities is massive.)
- 1,043,268,989 — Anti-Dilutive Securities (As of June 30, 2025, representing a massive potential dilution if the company ever becomes profitable.)
Key Players & Entities
- First Choice Healthcare Solutions, Inc. (company) — registrant
- FCID Medical, Inc. (company) — wholly owned subsidiary
- First Choice Medical Group of Brevard, LLC (company) — original medical services practice
- The Good Clinic Properties, LLC (company) — wholly owned subsidiary
- Securities and Exchange Commission (regulator) — filing recipient
- $2,037,329 (dollar_amount) — net loss for six months ended June 30, 2025
- $5,456 (dollar_amount) — revenue for six months ended June 30, 2025
- $471,300 (dollar_amount) — PPP Loan Forgiveness
- $6,454 (dollar_amount) — cash and cash equivalents as of June 30, 2025
- $69,818,477 (dollar_amount) — accumulated deficit as of June 30, 2025
FAQ
What were First Choice Healthcare Solutions' revenues for the six months ended June 30, 2025?
First Choice Healthcare Solutions, Inc. reported revenues, net of discounts, of $5,456 for the six months ended June 30, 2025. This represents a significant decrease from $10,154 reported for the same period in 2024.
What was the net loss for First Choice Healthcare Solutions for the second quarter of 2025?
For the three months ended June 30, 2025, First Choice Healthcare Solutions, Inc. reported a net loss of $639,436. This is an improvement compared to the net loss of $1,862,361 for the three months ended June 30, 2024.
How much cash and cash equivalents did First Choice Healthcare Solutions have as of June 30, 2025?
As of June 30, 2025, First Choice Healthcare Solutions, Inc. had cash and cash equivalents totaling $6,454. This is a substantial decrease from $19,915 reported at December 31, 2024.
Did First Choice Healthcare Solutions receive any PPP loan forgiveness in 2025?
Yes, First Choice Healthcare Solutions, Inc. recognized $471,300 in PPP Loan Forgiveness during the six months ended June 30, 2025, which was recorded as other income.
What is the total accumulated deficit for First Choice Healthcare Solutions as of June 30, 2025?
As of June 30, 2025, First Choice Healthcare Solutions, Inc. reported an accumulated deficit of $69,818,477. This indicates a long history of operating losses.
What are the primary business activities of First Choice Healthcare Solutions?
First Choice Healthcare Solutions, Inc. is actively engaged in implementing a growth strategy to build a network of localized, integrated healthcare services platforms. These platforms include nurse practitioner-driven primary care clinics offering services such as family primary care, anti-aging, dermatology, weight loss, hormone replacement therapy, functional and genetic testing, nutritional counseling, and behavioral health.
What are the total liabilities for First Choice Healthcare Solutions as of June 30, 2025?
As of June 30, 2025, First Choice Healthcare Solutions, Inc. had total liabilities of $38,778,384. This includes $10,339,589 in accounts payable and accrued expenses and $24,976,240 in notes payable.
How many common shares of First Choice Healthcare Solutions were outstanding as of August 13, 2025?
As of August 13, 2025, there were 32,958,288 shares outstanding of First Choice Healthcare Solutions, Inc.'s Common Stock, par value $0.001.
What is the basic and diluted loss per common share for First Choice Healthcare Solutions for the six months ended June 30, 2025?
The basic and diluted loss per common share for First Choice Healthcare Solutions, Inc. was $0.06 for the six months ended June 30, 2025. This is an improvement from $0.09 for the same period in 2024.
What are the significant risks facing First Choice Healthcare Solutions based on this filing?
Significant risks include severe liquidity issues with only $6,454 in cash, a substantial accumulated deficit of $69,818,477, and a significant decline in revenue by 46.3% for the six months ended June 30, 2025. The company also carries high debt, with notes payable at $24,976,240, and faces potential massive dilution from over 1 billion anti-dilutive securities.
Risk Factors
- Severe Liquidity Constraints [high — financial]: Cash and cash equivalents have plummeted to $6,454 as of June 30, 2025, a sharp decline from $19,915 at December 31, 2024. This critical reduction in liquidity poses an immediate threat to the company's ability to meet its short-term obligations.
- Increasing Debt Load [high — financial]: Total liabilities have increased to $38,778,384 as of June 30, 2025, from $36,982,542 at December 31, 2024. This increase is primarily driven by a rise in notes payable to $24,976,240 and accounts payable/accrued expenses to $10,339,589.
- Persistent Operating Losses [high — financial]: The company reported an operating loss of $1,158,872 for the six months ended June 30, 2025, which is a widening from $975,821 in the same period of 2024. This indicates ongoing struggles in the core business operations.
- Substantial Accumulated Deficit [high — financial]: The accumulated deficit has reached $69,818,477 as of June 30, 2025. This substantial deficit reflects a long history of unprofitability and negative equity, raising concerns about the company's long-term viability.
- Declining Revenue [high — financial]: Revenue, net of discounts, decreased substantially by 46.3% to $5,456 for the six months ended June 30, 2025, compared to $10,154 in the same period of 2024. This significant drop in revenue signals a severe decline in business activity.
- Potential for Massive Dilution [medium — financial]: The company has 1,043,268,989 anti-dilutive securities outstanding as of June 30, 2025. If the company were ever to become profitable, these securities could lead to massive dilution for existing common shareholders.
Industry Context
The healthcare solutions industry is highly competitive and subject to rapid technological advancements and evolving regulatory landscapes. Companies in this sector often face challenges related to reimbursement policies, drug pricing, and the need for continuous innovation. First Choice Healthcare Solutions appears to be struggling to maintain market share and operational efficiency within this dynamic environment.
Regulatory Implications
As a healthcare solutions provider, FCHS is subject to stringent regulations concerning patient data privacy (e.g., HIPAA), product safety, and billing practices. Non-compliance can lead to significant fines, legal action, and reputational damage, further exacerbating the company's already precarious financial situation.
What Investors Should Do
- Avoid Investment
- Monitor for Turnaround Signs
- Assess Debt Covenants
Key Dates
- 2025-06-30: End of Second Quarter 2025 — Reporting period for the 10-Q, revealing significant net loss, declining revenue, severe liquidity issues, and increasing liabilities.
- 2025-06-30: PPP Loan Forgiveness — A $471,300 PPP loan was forgiven, providing a temporary boost to net income but not alleviating underlying operational and liquidity concerns.
- 2025-06-30: Accumulated Deficit Reaches $69.82M — Highlights the company's long-standing unprofitability and negative equity position.
- 2025-06-30: Cash and Cash Equivalents at $6.45K — Indicates critical liquidity challenges and potential inability to meet short-term obligations.
- 2024-12-31: End of Fiscal Year 2024 — Baseline for comparison of financial condition, showing an increase in liabilities and a decrease in cash from this point.
Glossary
- Accumulated Deficit
- The cumulative net losses of a company since its inception, representing negative retained earnings. (Indicates FCHS has a long history of unprofitability and negative equity, reaching $69,818,477 as of June 30, 2025.)
- Anti-Dilutive Securities
- Securities that, if converted or exercised, would increase the number of outstanding shares, potentially reducing earnings per share for existing shareholders. (FCHS has over 1 billion anti-dilutive securities, posing a significant future dilution risk if the company ever becomes profitable.)
- Cash and Cash Equivalents
- Highly liquid short-term investments that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value. (FCHS's cash position has critically declined to $6,454, highlighting severe liquidity issues.)
- Operating Loss
- The loss incurred from a company's normal business operations before accounting for interest and taxes. (FCHS's operating loss widened to $1,158,872 for the six months ended June 30, 2025, showing core business struggles.)
- PPP Loan Forgiveness
- The cancellation of a Paycheck Protection Program loan, where the borrower is no longer required to repay the loan amount. (FCHS had $471,300 in PPP loans forgiven, which was recognized as other income, providing a temporary financial benefit.)
Year-Over-Year Comparison
Compared to the prior year period, First Choice Healthcare Solutions has seen a significant 46.3% decrease in revenue, falling to $5,456 for the six months ended June 30, 2025. While the net loss improved by 34.4% to $2.04 million, this was partly due to $471,300 in PPP loan forgiveness. However, operating losses have widened, and liquidity has critically deteriorated, with cash and cash equivalents dropping to $6,454. Total liabilities have also increased, driven by higher notes payable and accounts payable, indicating a worsening financial condition despite the reduced net loss.
Filing Stats: 4,518 words · 18 min read · ~15 pages · Grade level 16.3 · Accepted 2025-08-13 16:06:51
Filing Documents
- form10-q.htm (10-Q) — 602KB
- ex31-1.htm (EX-31.1) — 18KB
- ex31-2.htm (EX-31.2) — 18KB
- ex32-1.htm (EX-32.1) — 10KB
- 0001641172-25-023472.txt ( ) — 3380KB
- fchs-20250630.xsd (EX-101.SCH) — 28KB
- fchs-20250630_cal.xml (EX-101.CAL) — 41KB
- fchs-20250630_def.xml (EX-101.DEF) — 100KB
- fchs-20250630_lab.xml (EX-101.LAB) — 231KB
- fchs-20250630_pre.xml (EX-101.PRE) — 177KB
- form10-q_htm.xml (XML) — 431KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 17 ITEM 3.
Quantitative and Qualitative Disclosures about Market Risk
Quantitative and Qualitative Disclosures about Market Risk 19 ITEM 4.
Controls and Procedures
Controls and Procedures 19
OTHER INFORMATION
PART II. OTHER INFORMATION ITEM 1.
Legal Proceedings
Legal Proceedings 20 ITEM 1A.
Risk Factors
Risk Factors 20 ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 ITEM 3. Defaults Upon Senior Securities 20 ITEM 4. Mine Safety Disclosures 20 ITEM 5. Other Information 20 ITEM 6. Exhibits 20
SIGNATURES
SIGNATURES 21 2 FIRST CHOICE HEALTHCARE SERVICES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in dollars) 2025 2024 As of June 30, 2025 As of December 31, 2024 (unaudited) ASSETS Current assets: Cash and cash equivalents $ 6,454 $ 19,915 Other Current Assets 9,459 72,270 Total current assets 15,913 92,185 Property, plant and equipment, net 154,756 222,816 Operating lease right-of-use assets 3,539,385 3,734,869 Deposits 512,541 461,132 Total assets $ 4,222,595 $ 4,511,002 LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable and accrued expenses $ 10,339,589 $ 8,634,991 Operating lease liabilities, current portion 377,910 367,125 Notes payable 24,976,240 24,272,066 Total current liabilities 35,693,739 33,274,182 Long term liabilities: PPP loan payable - 471,300 Operating lease liabilities, non-current portion 3,084,645 3,237,060 Total liabilities $ 38,778,384 $ 36,982,542 Stockholders' deficit: Series A Super Voting Preferred Stock; 4 shares authorized, issued and outstanding at June 30, 2025 and December 31, 2024 - - Series A Convertible Preferred stock; $ 0.01 par value, 40,000 shares authorized, 147 and 147 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 1 1 Preferred Stock Common stock, $ 0.001 par value, 100,000,000 shares authorized 32,958,288 and 32,958,288 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 32,958 32,958 Additional paid-in capital 35,229,729 35,276,650 Treasury stock, 74,453 common shares, at cost — — Accumulated deficit ( 69,818,477 ) ( 67,781,149 ) Total stockholders' deficit ( 34,555,789 ) ( 32,471,540 ) Total liabilities and stockholders' deficit $ 4,222,595 $ 4,511,002 See the accompanying notes to these unaudited condensed consolidated financial statements. 3 FIRST CHOICE HEALTHCARE SERVICES, INC. AND SUBS